Latest Breaking News On - Aadi bioscience - Page 4 : comparemela.com

Aadi Bioscience, Inc. (NASDAQ:AADI) Chairman Neil Desai Sells 17,772 Shares

Aadi Bioscience, Inc. (NASDAQ:AADI – Get Free Report) Chairman Neil Desai sold 17,772 shares of the company’s stock in a transaction dated Monday, April 1st. The shares were sold at an average price of $2.31, for a total value of $41,053.32. Following the completion of the sale, the chairman now directly owns 1,393,771 shares of […]

Neil-desai
Aadi-bioscience
Piper-sandler
Nasdaq
Tower-research-capital
Aadi-bioscience-company-profile
Schonfeld-strategic-advisors
Cubist-systematic-strategies
Jpmorgan-chase-co
Group-plc
Aadi-bioscience-inc
Get-free-report

US Overhauls Race Data to Add Middle Eastern, Hispanic Categories

US Overhauls Race Data to Add Middle Eastern, Hispanic Categories
bnnbloomberg.ca - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from bnnbloomberg.ca Daily Mail and Mail on Sunday newspapers.

Michigan
United-states
Mississippi
Israel
Rockville
Maryland
Dearborn
Morocco
Iran
Egypt
Iranians
America

Earnings Scheduled For March 13, 2024 - Aadi Bioscience (NASDAQ:AADI), ProFrac Holding (NASDAQ:ACDC)

Companies Reporting Before The Bell • Sangamo Therapeutics (NASDAQ:SGMO) is likely to report quarterly loss at $0.26 per share on revenue of $8.10 million.

United-states
American
Envirn-servs
Aadi-bioscience
Coherus-biosciences
Profrac-holding
Arcos-dorados-holdings
Magic-software
Quoin-pharmaceuticals
Adams-resources-energy
Navigator-holdings
Profire-energy

Aadi Bioscience (AADI) Files $150M Mixed Shelf

Aadi Bioscience (AADI) Files $150M Mixed Shelf
streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.

Aadi-bioscience

Aadi Bioscience, Inc. (NASDAQ:AADI) Chairman Sells $73,080.00 in Stock

Aadi Bioscience, Inc. (NASDAQ:AADI – Get Free Report) Chairman Neil Desai sold 42,000 shares of the company’s stock in a transaction that occurred on Thursday, February 1st. The shares were sold at an average price of $1.74, for a total value of $73,080.00. Following the completion of the sale, the chairman now owns 1,453,543 shares […]

Canada
Piper-sandler
Aadi-bioscience
Neil-desai
Barclays-plc
Group-plc
Nasdaq
Royal-bank
Aadi-bioscience-company-profile
Citigroup-inc
Aadi-bioscience-inc
Get-free-report